# Deep Extraction Worksheet

Source: `src-hcm-024`  
Title: `Anatomopathological staging of feline hypertrophic cardiomyopathy through quantitative evaluation based on morphometric and histopathological data`  
Method note: this worksheet is based on accessible abstract-level study framing and source-card-checked details, not full section-by-section extraction of the complete article text.

## Phase 0: Sequential Micro-Analysis

#### Unit 1: The paper treats diagnosis as both clinical and pathologic

- core_claim: feline HCM cannot be modeled as purely clinical or purely imaging-based; it also has an anatomopathological dimension.
- implicit_premise: severity architecture should stay linked to pathologic depth.
- relation_to_previous: opening staging rule.
- hard_details: the abstract states that diagnosis of feline HCM is both clinical and anatomopathological.
- tension_or_surprise: pathology is being used as an extension of disease architecture, not just postmortem description.

#### Unit 2: The study aims for repeatable quantitative staging

- core_claim: quantitative pathologic evaluation can be standardized and repeated.
- implicit_premise: the module can safely keep a staging-depth branch without reducing it to vague pathology language.
- relation_to_previous: turns pathology relevance into methodological value.
- hard_details: the abstract describes an original, complete, and repeatable quantitative anatomopathological evaluation.
- tension_or_surprise: the study is explicitly about usable staging structure, not just descriptive lesion cataloguing.

#### Unit 3: End-stage HCM has a remodeled phenotype

- core_claim: progression to end-stage HCM is marked by increased left-ventricular fibrous tissue deposition.
- implicit_premise: end-stage disease is not just more hypertrophy; it is a remodeled phenotype.
- relation_to_previous: identifies the core staging signal.
- hard_details: the abstract states that progression to end-stage phenotypes is primarily characterized by increased left-ventricular fibrous tissue deposition.
- tension_or_surprise: fibrosis becomes the lead feature of end-stage transition.

#### Unit 4: Fibrosis is linked to chamber dilation and vascular disease

- core_claim: end-stage progression tracks with left-ventricular lumen dilation, left-atrial dilation, and intramural coronary arteriosclerosis.
- implicit_premise: advanced HCM severity architecture should include chamber remodeling and vascular change.
- relation_to_previous: extends fibrosis into a multi-feature end-stage pattern.
- hard_details: the abstract reports associations with left-ventricular lumen dilation, left-atrial dilation, and increased intramural coronary arteriosclerosis.
- tension_or_surprise: end-stage HCM looks structurally different, not just quantitatively worse.

## Phase 1: Theme Reconstruction

## Theme: End-stage HCM should be modeled as a remodeled phenotype

This paper is important because it gives the HCM module a real end-stage architecture. Fibrosis, dilation, and coronary remodeling belong together.

### Hard Information

- quantitative anatomopathological staging was developed
- end-stage progression is characterized by increased LV fibrous tissue
- LV lumen dilation, LA dilation, and intramural coronary arteriosclerosis accompany progression

## Theme: Pathology depth should inform severity architecture

The paper supports keeping a deeper staging branch that links clinical recognition to advanced structural remodeling.

### Hard Information

- diagnosis is both clinical and anatomopathological
- quantitative pathologic assessment was described as original and repeatable

## Phase 2: Claim-Evidence Structure

### Staging Key Points

**Claim 1**
- support: the abstract explicitly links end-stage progression to fibrosis
- details: fibrotic remodeling is central to late-stage architecture
- implicit_premise: severity should not be defined by thickness alone

**Claim 2**
- support: chamber dilation and coronary arteriosclerosis increase with progression
- details: advanced disease includes altered chamber geometry and vascular pathology
- implicit_premise: endpoint-depth pages need a remodeled end-stage branch

## Phase 2.5: Write-Back Implications

### For `topics/hcm/mechanism-overview.md`

- keep fibrosis as a bridge from remodeling to end-stage phenotype

### For `topics/hcm/endpoint-handbook.md`

- keep pathology staging in the depth layer, not as a first-pass routine endpoint

## Phase 3: Promotion Check

- source_card_updates:
  - preserve fibrosis-plus-dilation as the end-stage pattern
  - keep pathology staging separate from routine first-pass diagnosis
- topic_write_back_targets:
  - `topics/hcm/mechanism-overview.md`
  - `topics/hcm/endpoint-handbook.md`
  - `topics/hcm/current-state-dashboard.md`
- not_safe_to_promote_yet:
  - any routine-clinic claim that pathology staging outranks echo-led recognition
  - any assumption that end-stage architecture applies equally to early HCM
- conflicts_with_existing_vault:
  - none; this worksheet deepens severity architecture cleanly
